Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Bhel 237.50 4.28
Hindalco 148.05 3.60
Reliance 929.15 0.57
Tata Stl 455.80 1.26
Sslt 248.15 4.42
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Kopran Limited
Kopran Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
BSE:524280NSE:KOPRANBloomberg:KOP@INReuters:KPRN.BO
Market Lot: 1Face Value: 10ISIN Demat: INE082A01010
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Business
Kopran (KOPRAN) is a healthcare company manufacturing pharmaceutical formulations and over-the-counter (OTC) natural products. It was incorporated on April 26, 1958 as a private limited company, converted into a public limited company on Aug. 24, 1984, and got its current name on Aug. 22, 1990. ...   More..
Future Plans
CEO Talk
Think of your heart, think Kopran. That could well be the motto of Kopran Ltd. the Indian pharma company that currently rules the roost in the domestic cardiovascular drugs market.  Surendra Somani
One To One
Recent news
Latest News
'Buy' Kopran; target Rs 15: Firstcall  -IRIS 04-Jul-13
Previous

 


Brief Financials (in Rs. Mn.)Detailed Quarterly
Period ending (months)30-Jun-2014(12)31-Mar-2013 (12)31-Mar-2012 (12)
Net sales 2941.602433.001924.50
Other Income13.2017.2055.60
Total Income2954.802450.201980.10
Cost of goods sold2593.302159.201772.20
OPBDIT361.50291.00207.90
PAT170.30120.6061.70
Gross Block---
Equity capital390.50390.50390.50
EPS (Rs.)-0.001.58
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-NA8.23 - 19.49
Debt / Equity (x)---
Operating margin (% of OI)12.211.910.5
Net margin (% of OI) 5.8 4.9 3.1
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Parijat House
1076, Dr E Moses Road
Worli
Mumbai
Maharashtra-400 018
PHONE
(022) 4366 1111
FAX
(022) 2495 0363
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer